Inventor · disambiguated record
Bryan C. Tieman
Also filed as: TIEMAN BRYAN · TIEMAN BRYAN C
16 granted patents·12 pending applications·34 citations·filing 2005–2024
91Inventor score
Top patents by PatentIndex Score
28 records- 0186US9371374B2HCV core lipid binding domain monoclonal antibodiesABBOTT LAB·Filed 2013·Granted Jun 21, 2016·4 cites·16 claims
- 0285US7731965B2Human ring specific BNP antibodiesABBOTT LAB·Filed 2005·Granted Jun 8, 2010·10 cites·2 claims
- 0383US8846036B2Antibodies that bind to mammalian NGAL and uses thereofBIRKENMEYER LARRY G·Filed 2008·Granted Sep 30, 2014·5 cites·28 claims
- 0483US8349325B2Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for makingABBOTT LAB·Filed 2009·Granted Jan 8, 2013·7 cites·3 claims
- 0581US7998480B2Human BNP immunospecific antibodiesABBOTT LAB·Filed 2008·Granted Aug 16, 2011·4 cites·20 claims
- 0675US11428694B2Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodiesABBOTT LAB·Filed 2021·Granted Aug 30, 2022·0 cites·9 claims
- 0774US9469686B2Anti-GP73 monoclonal antibodies and methods of obtaining the sameABBOTT LAB·Filed 2013·Granted Oct 18, 2016·2 cites·11 claims
- 0872US10308709B2Anti-GP73 monoclonal antibodies and methods of obtaining the sameABBOTT LAB·Filed 2016·Granted Jun 4, 2019·1 cites·5 claims
- 0971US2019162726A1Anti-t. cruzi antibodies and methods of useABBOTT LAB·Filed 2018·Application pending·0 cites
- 1071US2020141937A1Detection methods employing hcv core lipid and dna binding domain monoclonal antibodiesABBOTT LAB·Filed 2019·Application pending·0 cites
- 1169US2009203037A1Anti-T. Cruzi Antibodies and Methods of UseABBOTT LAB·Filed 2008·Application pending·0 cites
- 1268US11421023B2Anti-GP73 monoclonal antibodies and methods of obtaining the sameABBOTT LAB·Filed 2019·Granted Aug 23, 2022·0 cites·5 claims
- 1368US2020033344A1Detection methods employing hcv core lipid and dna binding domain monoclonal antibodiesABBOTT LAB·Filed 2019·Application pending·0 cites
- 1466US7939069B2Human BNP immunospecific antibodiesABBOTT LAB·Filed 2007·Granted May 10, 2011·1 cites·22 claims
- 1564US10215754B2Anti-T. cruzi antibodies and methods of useABBOTT LAB·Filed 2016·Granted Feb 26, 2019·0 cites·6 claims
- 1662US10345311B2Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodiesABBOTT LAB·Filed 2016·Granted Jul 9, 2019·0 cites·12 claims
- 1762US10197573B2HCV core lipid binding domain monoclonal antibodiesABBOTT LAB·Filed 2016·Granted Feb 5, 2019·0 cites·18 claims
- 1861US9482667B2Anti-T. cruzi antibodies and methods of useABBOTT LAB·Filed 2015·Granted Nov 1, 2016·0 cites·13 claims
- 1961US9073984B2Anti-T. cruzi antibodies and methods of useBROPHY SUSAN E·Filed 2012·Granted Jul 7, 2015·0 cites·11 claims
- 2061US2024201202A1METHODS FOR DETECTING IMMUNOGLOBULIN G, SUBCLASS 4 (IgG4) IN A BIOLOGICAL SAMPLEABBOTT LAB·Filed 2024·Application pending·0 cites
- 2160US10444242B2Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodiesABBOTT LAB·Filed 2016·Granted Oct 15, 2019·0 cites·8 claims
- 2255US2023258638A1Methods and kits for detecting or determining an amount of an anti-b-coronavirus antibody in a sampleABBOTT LAB·Filed 2022·Application pending·0 cites
- 2355US2009148866A1Antibodies and Improved Test Sample Handling Methods for Use in Assays for MyeloperoxidaseABBOTT LAB·Filed 2008·Application pending·0 cites
- 2451US2009123946A1Immunoassays and kits for the detection of ngalABBOTT LAB·Filed 2008·Application pending·0 cites
- 2550US2009124022A1Antibodies that bind to mammalian ngal and uses thereofABBOTT LAB·Filed 2008·Application pending·0 cites
- 2649US2009269777A1Immunoassays and kits for the detection of ngalABBOTT LAB·Filed 2008·Application pending·0 cites
- 2748US2013040407A1SOLUBLE FMS-LIKE TYROSINE KINASE-1 (sFLT-1) ANTIBODY AND RELATED COMPOSITION, KIT, METHODS OF USING, AND MATERIALS AND METHOD FOR MAKINGABBOTT LAB·Filed 2012·Application pending·0 cites
- 2840US2010227775A1Immunoassays and kits for the detection of ngalABBOTT LAB·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bryan C. Tieman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →